KEGG   DRUG: Rurioctocog alfa
Entry
D05409                      Drug                                   

Name
Rurioctocog alfa (genetical recombination) (JAN);
Advate (TN)
Class
Cardiovascular agent
 DG02016  Hemostatics
  DG02013  Blood coagulation factor
  DG02014  Blood coagulation accelerant
   DG02013  Blood coagulation factor
Remark
Therapeutic category: 6349
ATC code: B02BD02
Chemical structure group: DG00170
Product (DG00170): D08798<JP> D05409<JP> D10227<JP> D10539<JP> D10758<JP> D10759<JP> D10760<JP> D10771<JP> D10818<JP> D10842<JP>
Efficacy
Bleeding suppressant, Replenisher (coagulation factor)
Comment
recombinant Factor VIII (BDDrFVIII) [HSA:2157] [KO:K03899]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B02 ANTIHEMORRHAGICS
   B02B VITAMIN K AND OTHER HEMOSTATICS
    B02BD Blood coagulation factors
     B02BD02 Coagulation factor VIII
      D05409  Rurioctocog alfa (genetical recombination) (JAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   634  Human blood preparations
    6349  Others
     D05409  Rurioctocog alfa (genetical recombination) (JAN)
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D05409
Other DBs
PubChem: 17398296
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system